Jefferies Group LLC Gilead Sciences, Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$59.54 - $68.01 $11.9 Million - $13.6 Million	-200,500 Reduced 90.93%	20,000 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.19 Million - $1.36 Million	20,000 New	20,000 $1.23 Million
Q1 2022 Sep 21, 2023	SELL	$57.92 - $72.58 $15 Million - $18.8 Million	-259,300 Reduced 54.04%	220,500 $13.1 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $15 Million - $18.8 Million	-259,300 Reduced 54.04%	220,500 $13.1 Million
Q4 2021 Sep 21, 2023	BUY	$64.88 - $73.64 $14.5 Million - $16.4 Million	223,300 Added 87.06%	479,800 $34.8 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $14.5 Million - $16.4 Million	223,300 Added 87.06%	479,800 $34.8 Million
Q3 2021 Sep 21, 2023	BUY	$67.69 - $73.03 $3.81 Million - $4.11 Million	56,300 Added 28.12%	256,500 $17.9 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $3.81 Million - $4.11 Million	56,300 Added 28.12%	256,500 $17.9 Million
Q2 2021 Aug 20, 2021	SELL	$63.47 - $69.35 $1.26 Billion - $1.37 Billion	-19,819,800 Reduced 99.0%	200,200 $13.8 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.26 Billion - $1.37 Billion	19,819,800 Added 9900.0%	20,020,000 $13.8 Million
Q1 2021 Sep 21, 2023	BUY	$60.0 - $68.46 $10.8 Million - $12.3 Million	180,200 Added 901.0%	200,200 $12.9 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $4.52 Million - $5.16 Million	75,300 Added 60.29%	200,200 $12.9 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $13.4 Million - $16.8 Million	-215,400 Reduced 63.3%	124,900 $7.89 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $5.44 Million - $6.32 Million	-75,200 Reduced 18.1%	340,300 $26.2 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $2.81 Million - $3.59 Million	44,800 Added 12.09%	415,500 $31.1 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $12.9 Million - $14.2 Million	208,800 Added 128.97%	370,700 $24.1 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $218,785 - $241,500	-3,500 Reduced 2.12%	161,900 $10.3 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $6.01 Million - $6.74 Million	97,200 Added 142.52%	165,400 $11.2 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $12.1 Million - $13.5 Million	-193,400 Reduced 73.93%	68,200 $4.43 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $102,918 - $134,300	-1,700 Reduced 0.65%	261,600 $16.4 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $2.47 Million - $2.74 Million	34,700 Added 15.18%	263,300 $20.3 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $14 Million - $16.4 Million	216,300 Added 1758.54%	228,600 $16.2 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.38 Million - $1.69 Million	-19,000 Reduced 60.7%	12,300 $927,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $2.23 Million - $2.61 Million	31,300	31,300 $2.24 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

Black Rock Inc. New York, NY

121M
Shares

$10.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$9.66 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.39 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.07 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$4.97 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account